相关实验视频
Updated: Feb 19, 2026

07:44
Evaluation of Synapse Density in Hippocampal Rodent Brain Slices
Published on: October 6, 2017
18.2K
通过增加RhoA减少了Kctd13的突触传输
Christine Ochoa Escamilla1, Irina Filonova1, Angela K Walker1
1Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8813, USA.
Nature
|November 2, 2017
概括
在小鼠中删除Kctd13基因减少了突触传播,使KCTD13与神经精神疾病相关的神经功能相关. 这项研究阐明了Kctd13
科学领域:
- 神经科学
- 遗传学
- 发育生物学
背景情况:
- 在16p11.2染色体区域的拷贝数变异与神经精神疾病有关,包括自闭症谱系疾病.
- KCTD13是16p11.2区域内的基因,涉及神经发育表型,但其在哺乳动物大脑中的功能尚不清楚.
研究的目的:
- 研究KCTD13基因在哺乳动物大脑中的功能.
- 确定KCTD13在突触传播,神经发生和大脑大小中的作用.
- 探索KCTD13功能的潜在治疗影响.
主要方法:
- 在小鼠模型中删除Kctd13基因.
- 对突触传播的评估.
- 测量Ras同类基因家族成员A (RhoA) 的水平.
- 药理上抑制RhoA.
- 在小鼠和斑马鱼中评估大脑大小和神经发生.
主要成果:
- 在小鼠中删除Kctd13导致突触传播减少.
- 降低的突触传输与增加的RhoA水平相关,并通过RhoA抑制逆转.
- 与之前的淘汰研究相反,Kctd13的删除并没有导致小鼠或斑马鱼的大脑大小或神经生成的增加.
结论:
- 在调节神经元功能,特别是突触传播方面,KCTD13起着至关重要的作用.
- 增加RhoA信号是KCTD13缺失对神经元功能影响的关键机制.
- KCTD13不是大脑大小或神经生成的重要调节者.
- 对于与KCTD13删除相关的神经精神疾病,RhoA可能是潜在的治疗点.
相关概念视频
Enzyme-linked Receptors
87.0K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
87.0K
Small GTPases - Ras and Rho
5.5K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.5K
Drugs Affecting Neurotransmitter Synthesis
2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K
Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Desensitization and Tachyphylaxis
3.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.2K
Excitatory and Inhibitory Effects of Neurotransmitters
13.5K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
13.5K

